New technique improves T cell-based immunotherapies for solid tumors Scripps Research scientists help T cells more effectively kill solid tumors cells in vitro and in mice by tweaking an existing cancer immunotherapy.
May 01, 2024
LA JOLLA, CA Scientists from Scripps Research have enhanced an existing immunotherapy by removing the sugar coating surrounding solid tumors such as in melanoma, breast, and prostate cancer so T cells can more effectively kill tumor cells. They report in the journal Nature Biomedical Engineering on May 1, 2024, that this tweak allows T cells to get closer to their targets, which dramatically improves T-cell killing of tumor cells in mouse models.
Compared to blood tumors, solid tumors are resistant to treatment because they build a physical fort around themselves to block immune cells from entering and attacking. Part of this fort is made up of layers of sugar molecules, the outermost of which is a substance called sialic acid. To remove this sialic acid barrier, the research team fused the enzyme sialidase onto cancer therapy agents called bispecific T-cell engager (BiTE) molecules. These molecules typically work by activating a patient's own T cells against the cancer.
Solid tumors form a microenvironment around themselves that is immunosuppressive, says senior author Peng Wu, PhD, a professor in the Department of Molecular Medicine at Scripps Research. Immune cells have to enter this solid mass which is covered with sialic acid molecules that physically block T cells from infiltrating. The idea here is to introduce sialidase to the T-cell engager to chop off sialic acid from the outside of the tumor mass so that T cells have a better chance to enter.
BiTE molecules have two binding sites one that binds to molecules on tumor cell surfaces called antigens, and one that binds to the T-cell receptor complex. Several BiTE therapies are already FDA-approved, but they all target blood cancers (such as blinatumomab, which targets B-cell leukemia). However, clinical trials against solid tumors, which make up 90% of tumors, have had limited success.
All of the approved drugs for T-cell engager molecules are against blood tumors, because all of the BiTE clinical trials against solid tumors have been pretty underwhelming, says first author Zhuo Yang, PhD, who recently completed his PhD at Scripps Research under the guidance of Wu and the late Richard Lerner, MD. Were really hoping the strategy that we present here may have the potential to make a breakthrough for T-cell engaging therapies against solid tumors.
The researchers tested the fusion of sialidase to several different BiTE molecules targeting different types of cancer, including antigens associated with breast, B-cell and prostate cancers. In all cases, the addition of sialidase to create these fusion molecules improved T-cell killing in a lab dish (in vitro). In collaboration with Rutgers University, the research used fluorescent microscopy to show that these fusion molecules resulted in a much larger contact area (or immunological synapse ) between T cells and the tumor cells that enables better tumor killing.
Next, the researchers tested the fusion molecule's efficacy at treating solid tumors in mice. They found that mice that were treated with the fusion molecule had delayed tumor growth, smaller tumors, and were more likely to survive compared to mice treated with regular BiTE molecules. In one of the cancer models, treatment with the fusion molecule completely eradicated the tumors for two out of five mice.
The researchers also observed an altered microenvironment surrounding the tumor, which they credit with these improved treatment outcomes. In the presence of the fusion molecule, we have better infiltration of T cells and natural killer cells, which are good cells for killing tumors, and less accumulation of immunosuppressive cells, says Wu. So basically, the fusion molecule can convert an immunosuppressive tumor microenvironment into a more immune-permissive one.
Though the team hypothesized that adding sialidase would improve T-cell engagement, they were surprised by how much of a difference it made. By simply cutting off one single sugar thats overexpressed on the surface of tumor cells, we can have huge enhancements, says Yang. There are many sugars on the surface of tumor cells and we're only getting rid of the first layer, so we were not expecting to see such dramatic effects.
Eventually, the researchers hope that their technology will help treat human cancer patients, but first they will need to engineer the molecules to make them more suitable for humans. They also hope to inspire more cancer researchers to consider sugars when designing therapeutics.
Tumor cells have unique sugar patterns, but people rarely consider them, says Wu. Were hoping that in the future more and more people will think about sugars when they are designing therapeutic strategies.
In addition to Wu and Yang, authors of the study, Targeted desialylation and cytolysis of tumour cells by fusing a sialidase to a bispecific T-cell engager, include Yingqin Hou, Geramie Grande, Chao Wang, Yujie Shi, Jaroslav Zak, Yue Wan, Ke Qin, John R. Teijaro, and the late Richard A. Lerner of Scripps Research; and Jong Hyun Cho and Dongfang Liu of Rutgers University-New Jersey Medical School.
This work was supported by the NIH and a Cancer Research Institute/Irvington postdoctoral fellowship.
Cancer Wu, Peng
Most recent headlines
09/11/2025
Dalet today announced a transformative leap forward for media operations: Agentic Artificial Intelligence (AI) that unifies the Dalet ecosystem under one natura...
16/10/2025
SVG Sit-Down: FUJIFILM Execs on GFX ETERNA 55 Camera, Importance of Shallow-Dept...
16/10/2025
Squash's Most Ambitious Broadcast Production To Be Deployed at Comcast Busin...
16/10/2025
Main Street Sports Group Inks Deal With Omaha Productions, Launches Original-Con...
16/10/2025
A Historic Precursor? FIFA, HBS, DAZN Offer an Inside Look at Production of FIFA...
16/10/2025
Prime Video Offers Sneak Peak at New NBA on Prime StudioThe massive 13,000-sq-ft, two-story studio features a LED regulation half court and hoopBy Jason Dachman...
16/10/2025
SVG Remote Production Forum Draws Record Crowd for Visit to PGA TOUR Studios, De...
16/10/2025
BitFire's Ben Grafchik on How Growing Cloud Workflows Are Impacting the Live...
16/10/2025
AI technology is advancing quickly, bringing both new creative possibilities and...
16/10/2025
In 2017, Imani Ellis launched CultureCon, a conference that's become a must-attend event for more than 10,000 diverse creatives and Black professionals to c...
16/10/2025
It might still be a little early to break out the tinsel and mistletoe, but Spotify's already queuing up some holiday magic. This year's Spotify Singles...
16/10/2025
Earlier this year, our in-house publishing imprint, Spotify Audiobooks, put out ...
16/10/2025
VAMPIRE has been integrated onto GM Defenses Infantry Squad Vehicle (ISV), providing a mobile solution to effectively and affordably counter small drone threat...
16/10/2025
The AgilePod mounted on the host aircraft....
16/10/2025
60% say infotainment systems are a critical purchasing or leasing consideration,...
16/10/2025
NEW YORK The Broadcasters Foundation of America has launched its 2025 Year-End Giving Campaign, which seeks to raise donations from tax-deductible personal and ...
16/10/2025
Roku has added several new features to its user interface and operating system meant to make it easier to discover and personalize content, the company said....
16/10/2025
NEW YORK CNN has announced that its All Access subscription tier will launch in the U.S. on Oct. 28, providing audiences with a centralized destination for CNN&...
16/10/2025
Student Spotlight: Alan Villanueva The graduate student and saxophonist, who performed on Natalia Lafourcades Latin Grammy-nominated Live at Carnegie Hall alb...
16/10/2025
The XR Sports Alliance (XRSA) has announced the third cohort of members. The new members include Maple Leafs Sports & Entertainment (MLSE), the Vegas Golden Kni...
16/10/2025
NEW YORK The Broadcasters Foundation of America has launched its 2025 Year-End Giving Campaign which seeks to raise donations from tax-deductible personal and c...
16/10/2025
NEW YORK Australia's Nine Network and the NHL today announced a media partnership that will bring the world's premier professional ice hockey league to ...
16/10/2025
Parks Associates has released new data showing that nearly half (45%) of U.S. internet homes watch free ad-supported streaming TV (FAST) services and 89% of U.S...
16/10/2025
TROY, Mich. -New data from J.D. Power's 2025 U.S. Residential Internet Service Provider Study shows that residential wireless internet providers are growing...
16/10/2025
TV's most charming detective drama * Shakespeare & Hathaway: Private Investi...
16/10/2025
Back to All News
Thailand's Legendary Outlaw Returns: Tee Yai: Born to be ...
16/10/2025
Back to All News
Christmas Is Just Around The Corner: Home For Christmas Season...
16/10/2025
Back to All News
Trist n Ulloa Stars in El crimen de Pazos, the New Netflix Ser...
16/10/2025
ABS Completes Redomiciliation to Dubai Development Authority as Part of Strategi...
16/10/2025
This Saturday October 18 Katja Mia will burst onto the radio airwaves for the first time as she joins 2FM. Katja will be standing in for Bl thnaid Treacy on Sat...
16/10/2025
This October, RT is delighted to support Wexford Festival Opera, Babor International Arts Festival for Children, Open House Dublin and 36 other arts and cultu...
16/10/2025
GeForce NOW is more than just a platform to stream fresh games every week - it offers celebrations for the gamers who make it epic, with member rewards to sweet...
15/10/2025
Across the world, early-career reporters are interrogating systems that shape daily life, from mortuaries and classrooms to the corridors of legal education and...
15/10/2025
St. Louis Blues Pay Tribute to Ozzy Osbourne in New Pregame Open VideoThe NHL franchise worked with production firms 2WEI and 4th Floor CreativeBy Mark J Burns,...
15/10/2025
Cobalt Digital, G3DVu, Proxima Vision, and Telos Alliance Renew Premier Sponsors...
15/10/2025
By Paige Bethmann
Before my grandmother passed away in 2019, I went to visit her in the hospital where she'd been for a few weeks. When I arrived, the nurs...
15/10/2025
Two years ago, Spotify set out to grow the entire publishing industry by making ...
15/10/2025
People turn to DJ for a listening experience that feels personal, dynamic, and j...
15/10/2025
Las personas recurren a DJ para vivir una experiencia de escucha personal, din m...
15/10/2025
Rock legend Bruce Springsteen and luminary actor Jeremy Allen White came togethe...
15/10/2025
At Spotify, we're all about supporting rising talent and helping them connec...
15/10/2025
New SBS Documentary Series THE CANCER KILLERS Premieres 4 November on SBS & SBS ...
15/10/2025
SBS celebrates the Festivals of Lights with bold, illuminating stories across th...
15/10/2025
One of humanity's most profound questions continues: Is there any place in our galaxy suitable for life beyond Earth? NASA intends to find out, with the hel...
15/10/2025
eds3_5_jq(document).ready(function($) { $(#eds_sliderM519).chameleonSlider_2_1({ content_source:......
15/10/2025
Scality, a global leader in cyber-resilient storage software for the AI era, today announced the advancement of its comprehensive AI ecosystem certification pro...
15/10/2025
The Hollywood Professional Association (HPA) today unveiled key highlights of the 2026 HPA Tech Retreat, scheduled for Feb. 15 19 at the Westin Rancho Mirage Go...
15/10/2025
At NAB Show New York 2025 (Stand 244), Interra Systems will showcase the future of media QC, monitoring, and captioning, highlighting its award-winning, AI- and...
15/10/2025
Grass Valley today announced that RMC BFM, part of the CMA-CGM Group and France's third-largest private media group, has chosen Grass Valley's productio...
New technique improves T cell-based immunotherapies for solid tumors Scripps Research scientists help T cells more effectively kill solid tumors cells in vitro and in mice by tweaking an existing cancer immunotherapy.
